The results indicated that MAPK and NF-κB signaling were attenuated and persisted for fewer periods of time in ESCC cells when TNFR1 m6A modifications were removed (Figure 4G). This evidence concerns the gene NFKB1 and esophageal squamous cell carcinoma.